C12Y 306/03014
H+-transporting two-sector atpase , i.e. f1 atpase
Official title: H+-transporting two-sector ATPase (3.6.3.14), i.e. F1 ATPase
C12Y306/03014 (H+-transporting two-sector atpase , i.e. f1 atpase) appears on 13 US grants and 21 published applications in this corpus.
Search patents in C12Y- Granted patents
- 13
- Published applications
- 21
- Assignees
- 22
- Inventors
- 53
- Latest grant
- 16 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 0 |
| 2003 | 0 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 1 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 1 |
| 2010 | 0 | 1 |
| 2011 | 0 | 0 |
| 2012 | 0 | 1 |
| 2013 | 1 | 1 |
| 2014 | 1 | 1 |
| 2015 | 2 | 2 |
| 2016 | 0 | 2 |
| 2017 | 0 | 2 |
| 2018 | 1 | 0 |
| 2019 | 1 | 0 |
| 2020 | 2 | 1 |
| 2021 | 1 | 0 |
| 2022 | 0 | 3 |
| 2023 | 0 | 0 |
| 2024 | 0 | 1 |
| 2025 | 1 | 2 |
| 2026 | 1 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Peptide antigens and uses thereof16 Jun 2026US 12,653,873 B2Humanitas Mirasole S.P.A.
- Methods of determining pH and calcium or chloride concentration in samples7 Oct 2025US 12,436,156 B2The University of Chicago
- Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof12 Oct 2021US 11,141,456 B2Stealth BioTherapeutics Inc.
- Polypeptide targeting to mitochondria24 Mar 2020US 10,596,227 B2United Kingdom Research and Innovation
- Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof3 Mar 2020US 10,576,124 B2Stealth BioTherapeutics Inc.
- 5'-utr variant sequences and use thereof20 Aug 2026US 2026/0242836 A1Cj Cheiljedang Corporation
- Novel atp synthase variant and method of producing l-aromatic amino acid using the same29 May 2025US 2025/0171747 A1Daesang Corporation
- A method of treating acute myeloid leukemia6 Feb 2025US 2025/0043270 A1Agency for Science, Technology and Research
- Fluorescent sensors and methods of making and using28 Nov 2024US 2024/0393319 A1
- Peptide antigens and uses thereof13 Oct 2022US 2022/0323557 A1Humanitas Mirasole S.P.A.
Most cited
By later US patents
- Modulation of blood brain barrier protein expression10US 8,466,118 B2Saint Louis University · 2013
- Vacuolar atpase subunit AC455US 5,932,444 AIncyte Pharmaceuticals, Inc. · 1999
- Polypeptide targeting to mitochondria4US 9,139,628 B2Medical Research Council · 2015
- Mitochondrial targeted RNA expression system and use thereof2US 8,883,755 B2University of Pittsburgh—Of the Commonwealth System of Higher Education · 2014
- Therapeutic compositions including frataxin, lactoferrin, and mitochondrial energy generating enzymes, and uses thereof1US 10,576,124 B2Stealth BioTherapeutics Inc. · 2020